Vol.

No.

April 17, 2020Apr 17, 2020

Free

DOWNLOAD THE PDF

Lowy: “Our patients are counting on us, and we must not let them down” NCI Frederick lab takes aim at Covid-19

Cover Story

COVID-19 & Cancer Free

Lowy: “Our patients are counting on us, and we must not let them down”

NCI Frederick lab takes aim at Covid-19

By Matthew Bin Han Ong

NCI’s Frederick National Laboratory for Cancer Research has launched three initiatives focused on SARS-CoV-2.

COVID-19 & Cancer Free

Doroshow: NCI to accrue patients for COVID-19 longitudinal cohort
Ongoing trials see significant decrease in accrual

By Matthew Bin Han Ong

COVID-19 & Cancer Free NCI Director's Report

Sharpless: NCI is fully operational, we have a moral obligation to help in the COVID-19 pandemic response

By Matthew Bin Han Ong

COVID-19 & Cancer Free

As treatments get cancelled because of COVID-19, patients worry about adequacy of care

By Alexandria Carolan

COVID-19 & Cancer Free

American Cancer Society announces a wave of furloughs and layoffs as COVID-19 constricts fundraising

By Alexandria Carolan

COVID-19 & Cancer Free Guest Editorial

Amid COVID-19 pandemic, cancer community responds to fill data gap

By Richard L. Schilsky

COVID-19 & Cancer Free Guest Editorial

Cancer care continues during COVID-19 pandemic—with new tools and old challenges

By Ted Okon

Conversation with The Cancer Letter COVID-19 & Cancer Free

Lichtenfeld: COVID-19 exposed weaknesses in the U.S. health care system

By Paul Goldberg

COVID-19 Updates

AstraZeneca trial to test Calquence in COVID-19 patients

Clinical trial accruals at OneOncology increase in the face of COVID-19

American Cancer Society opens COVID-19 tracking study

Research!America urges Congress to modify budget caps, increase FY21 funding for health agencies

NAS, NAE, and NAM presidents: U.S. funding for WHO should not be interrupted during COVID-19 pandemic

White House expands coverage for essential diagnostic services

Bipartisan bill proposes telehealth expansion

Nebraska Medical Center develops infectious aerosol capture mask to protect health care workers

FDA authorizes blood purification device to treat COVID-19

Adolescent, young adult cancer non-profits provide guidance on COVID-19

FAQs and Guidances

In Brief

J. Alan Diehl named deputy director and chief operating officer of Case CCC

Andres F. Correa joins Fox Chase Cancer Center

Esther Welkowsky named VP, clinical operations, at Elicio Therapeutics

Clinical Roundup

Elicio Therapeutics and NCI study ELI-002 mutant KRAS targeting mechanism

ACS study: JUUL sales bounced back within weeks of self-imposed flavor ban

Chronic stress can impact response to radiation therapy

Drugs & Targets

FDA approves Koselugo for neurofibromatosis type 1

FDA approves mitomycin for low-grade upper tract urothelial cancer

Ontruzant, biosimilar of Herceptin, introduced in the U.S.

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues

Volume 50 | Issue 44 - November 22, 2024

Lowy: “Our patients are counting on us, and we must not let them down”

Doroshow: NCI to accrue patients for COVID-19 longitudinal cohort
Ongoing trials see significant decrease in accrual

Sharpless: NCI is fully operational, we have a moral obligation to help in the COVID-19 pandemic response

As treatments get cancelled because of COVID-19, patients worry about adequacy of care

American Cancer Society announces a wave of furloughs and layoffs as COVID-19 constricts fundraising

Amid COVID-19 pandemic, cancer community responds to fill data gap

Cancer care continues during COVID-19 pandemic—with new tools and old challenges

Lichtenfeld: COVID-19 exposed weaknesses in the U.S. health care system

COVID-19 Updates

AstraZeneca trial to test Calquence in COVID-19 patients

Clinical trial accruals at OneOncology increase in the face of COVID-19

American Cancer Society opens COVID-19 tracking study

Research!America urges Congress to modify budget caps, increase FY21 funding for health agencies

NAS, NAE, and NAM presidents: U.S. funding for WHO should not be interrupted during COVID-19 pandemic

White House expands coverage for essential diagnostic services

Bipartisan bill proposes telehealth expansion

Nebraska Medical Center develops infectious aerosol capture mask to protect health care workers

FDA authorizes blood purification device to treat COVID-19

Adolescent, young adult cancer non-profits provide guidance on COVID-19

FAQs and Guidances

In Brief

J. Alan Diehl named deputy director and chief operating officer of Case CCC

Andres F. Correa joins Fox Chase Cancer Center

Esther Welkowsky named VP, clinical operations, at Elicio Therapeutics

Clinical Roundup

Elicio Therapeutics and NCI study ELI-002 mutant KRAS targeting mechanism

ACS study: JUUL sales bounced back within weeks of self-imposed flavor ban

Chronic stress can impact response to radiation therapy

Drugs & Targets

FDA approves Koselugo for neurofibromatosis type 1

FDA approves mitomycin for low-grade upper tract urothelial cancer

Ontruzant, biosimilar of Herceptin, introduced in the U.S.

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login